Signaling Pathway
Lunsekimig is a multispecific monoclonal antibody comprising five tandemly linked variable heavy chain domains that target thymic stromal lymphopoietin (TSLP), interleukin-13 (IL-13), and albumin (ALB). This engineered format offers enhanced functionality and half-life extension and is used in research on allergic inflammation and respiratory diseases such as asthma.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Lunsekimig is a multispecific monoclonal antibody comprising five tandemly linked variable heavy chain domains that target thymic stromal lymphopoietin (TSLP), interleukin-13 (IL-13), and albumin (ALB). This engineered format offers enhanced functionality and half-life extension and is used in research on allergic inflammation and respiratory diseases such as asthma. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
